ANTICARDIOLIPIN ANTIBODY TEST SYSTEM— 510(k) K903531

Substantially Equivalent

Medical Innovations Corp.

FDA 510(k) clearance K903531 for ANTICARDIOLIPIN ANTIBODY TEST SYSTEM, Substantially Equivalent on 1991-01-25. Applicant: Medical Innovations Corp..

Clearance details

Applicant: Medical Innovations Corp.
Product code: Code GFO
Advisory panel: Hematology
Date received: 1990-08-06
Decision date: 1991-01-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Portland, OR, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.